Search Results 201-210 of 578 for ❗베스트토토【평생베스트.com】베스트토토검증❗

  1. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  2. A Study Using Avelumab in Non-Small Cell Lung Cancer that has Progressed - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  3. Gastroenterology and Hepatology - Clinical trials

    Mayo Clinic in Rochester, Minnesota, has been recognized as the best Gastroenterology & GI Surgery hospital in the nation for 2024-2025 by U.S. News & World ...

  4. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  5. Neurology - Clinical trials

    We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

  6. Pharmacogenomics: RIGHT 10K Study - Center for Individualized Medicine - Mayo Clinic Research

    The Mayo Clinic Center for Individualized Medicine's RIGHT 10K Study looks at the impact of drug-gene pairing data and best-practice alerts in the ...

  7. Testicular Tissue Cryopreservation in Children - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 15-004891. NCT ID: NCT02872532. Sponsor Protocol Number: 15-004891. About this study. This protocol is being ...

  8. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  9. A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  10. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    ... best. Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...